INN35

Nom de l'organisation

Innate s.r.l.

SRN

IT-MF-000026730

Statut du fabricant

Actif

6 avertissements enregistrés — faire défiler le panneau pour tout voir.

• CW010

  EUDAMED n'a pas publié de description pour ce code.
• CW001

  EUDAMED n'a pas publié de description pour ce code.
• CW009

  EUDAMED n'a pas publié de description pour ce code.
• CW007

  EUDAMED n'a pas publié de description pour ce code.
• CW032

  EUDAMED n'a pas publié de description pour ce code.
• CW999

  Is suitable only for intra-articular injections and must only be dispensed by a doctor who has received specific training on the intra-articular injections technique. The device must not be used in pregnant or breastfeeding women, as has not been tested in such cases. The device must be not be used in patients with ascertained individual hypersensitivity to any of the ingredients of the product. As no clinical experience is available for the use of Hyaluronan in children, treatment with Promovia 40 is not recommended in these cases. After the intra-articular injection it is advisable to recommend to the patient to avoid physical activities demanding stress for the articulation and resume normal activities after a few days. After the intra-articular injection it is advisable to recommend to the patient to avoid driving for at least 48 hours. Is a disposable product, the quality and sterility are guaranteed only if the syringe is sealed. Before use, check the integrity of the syringe and the expiration date. The product should not be injected in the presence of a infected or severely inflamed joint. The infiltration must be avoided in the case of infection in place or inflammatory conditions of the skin in proximity of the injection. Do not use the product if the package is already opened or damaged. The assembled syringe must be discarded immediately after use, regardless of whether or not the solution has been completely administered. After use, dispose according to applicable national practice. For additional information consult instruction for use

Marché principal en Italie ; disponible dans 7 pays au total.

Dénomination commerciale

non renseigné

Code d'UDI-DI

08051040330079

Basic UDI-DI

B-08051040330079

Numéro de référence/catalogue

INN35

Entité d'attribution

GS1

Catégorie de risque

Classe III

Législation applicable

MDD [Directive 93/42/CEE relative aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

Is a synovial fluid substitute which, thanks to its viscoelastic and lubricant properties, promotes the restoration of rheological conditions of the joints, altered in degenerative or post-traumatic conditions. The product, improving the characteristics of the synovial fluid, exerts a protective action of the joints and helps the improvement of joint function and the reduction of pain symptoms. It acts only at the joint where it is injected, without exerting any systemic action.

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

• Numéro de lot
• Date d'expiration
• Date de fabrication
• Numéro de série
• Identification du logiciel

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• P900402RESORBABLE FILLING AND RECONSTRUCTION DEVICES

Santé des certificats sur le portefeuille de ce fabricant.